A special issue of human mutation has been released.
P53 status in cancer cell lines.
Using the nci 60 cell line panel as a model widely used in the literature the p53 status could not be ascertained for 13 cell lines due to a lack of homogeneous data in the literature.
The current version includes 2 000 and 500 cell lines with mutant tp53 and wild type tp53 respectively.
This special issue on tp53 propels the tp53 gene into the post genomic era.
The p53 mutations in cell lines compendium.
The tp53 gene network in the post genomic era.
P53 mutation status in human cancer cell lines 700 cancer biology therapy 2008.
Strikingly we found discrepancies in the p53 status for 23 88 384 of cell lines for which the p53 status was established independently in two laboratories.
Several fundamental features of wild type and mutant proteins and their modifications are reviewed as well as animal models and clinical aspects such as recommendations for patient care.
Knowledgebase and statistical tools for the analysis of tp53 gene mutations in human cancers.
7 issue 5 the distribution of mutations and in the pattern of mutational events when compared to tumors indicating that they are representative of the cells from which they were derived.